logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
R

Ryuji Hayashi

toyama university hospital
H指数:34
被引数:4,264

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Time to Treatment Failure as a Recorded Treatment-Process Measure in C-CAT. Reply to Comment on “Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462”

治疗失败时间作为C-CAT中记录的治疗过程指标。回复关于“肺癌中医疗机构层面的肿瘤学专家可用性与一线治疗失败时间：一项全国性C-CAT登记研究。Curr. Oncol. 2026, 33, 462”的评论

Current Oncology
IF3.4
2026-10-220
OA
Shinya Kajiura; Hironaga Satake; Ryuji Hayashi; Takayuki Yoshino
Deletion of Tgf-β1 From CD206+ M2 Macrophages Ameliorates Obesity-Induced Suppression of Myogenesis and AMPK Phosphorylation in Skeletal Muscle

从CD206+ M2型巨噬细胞中删除Tgf-β1可改善肥胖诱导的骨骼肌肌生成抑制和AMPK磷酸化

Journal of Cachexia Sarcopenia and Muscle
IF9.1
2026-07-280
OAAI
Muhammad Bilal; Le Duc Anh; Nguyen Quynh Phuong; Sana Khalid; Allah Nawaz; Memoona; Muhammad Rahil Aslam; Tomonobu Kado; Yoshiyuki Watanabe; Ayumi Nishimura; Yoshiko Igarashi; Aamir Sharif; Yasuhiro Onogi; Tsutomu Wada; Ryuji Hayashi; Kenichi Hirabayashi; Seiji Yamamoto; Takashi Nakagawa; Hisashi Mori; Isao Usui; Masaru Kato; Shiho Fujisaka; Kazuyuki Tobe
Facility-Level Availability of Japanese Society of Medical Oncology Specialists and Recorded First-Line Treatment-Process Duration in Pancreatic Cancer: A Nationwide Center for Cancer Genomics and Advanced Therapeutics Registry Analysis

日本临床肿瘤学会专科医师在机构层面的可用性与记录的胰腺癌一线治疗过程持续时间：一项全国癌症基因组学和先进治疗中心登记分析

Current Oncology
IF3.4
2026-07-020
OAAI
Shinya Kajiura; Hironaga Satake; Naohiko Nakamura; Ryuji Hayashi
TTF-1 expression is associated with survival in patients with non-squamous non-small cell lung cancer treated with immune checkpoint inhibitor therapy

TTF-1表达与接受免疫检查点抑制剂治疗的非鳞非小细胞肺癌患者的生存相关

Molecular and Clinical Oncology
IF1.4
2026-02-010
PRE
Murayama, Nozomu; Inomata, Minehiko; Furukawa, Daisuke; Hashizume, Moe; Takata, Naoki; Seto, Zenta; Tokui, Kotaro; Okazawa, Seisuke; Imanishi, Shingo; Miwa, Toshiro; Hayashi, Ryuji; Takagi, Kohji; Hirabayashi, Kenichi
An observational study on the efficacy of targeted therapy for pulmonary sarcomatoid carcinoma

关于靶向治疗对肺肉瘤样癌疗效的观察性研究

Discover Oncology
IF2.9
2024-08-290
OAAI
Takeshi Tsuda; Tomomi Ichikawa; Masahiro Matsumoto; Isami Mizusihima; Kenji Azechi; Naoki Takata; Nozomu Murayama; Kana Hayashi; Takahiro Hirai; Zenta Seto; Kotaro Tokui; Yasuaki Masaki; Chihiro Taka; Seisuke Okazawa; Kenta Kambara; Shingo Imanishi; Hirokazu Taniguchi; Toshiro Miwa; Ryuji Hayashi; Shoko Matsui; Minehiko Inomata
Structure-activity relationships of middle-size cyclic peptides, KRAS inhibitors derived from an mRNA display
BIOORGANIC & MEDICINAL CHEMISTRY
IF3
2024-08-013
PRE
Kage, Mirai; Hayashi, Ryuji; Matsuo, Atsushi; Tamiya, Minoru; Kuramoto, Shino; Ohara, Kazuhiro; Irie, Machiko; Chiyoda, Aya; Takano, Koji; Ito, Toshiya; Kotake, Tomoya; Takeyama, Ryuuichi; Ishikawa, Shiho; Nomura, Kenichi; Furuichi, Noriyuki; Morita, Yuya; Hashimoto, Satoshi; Kawada, Hatsuo; Nishimura, Yoshikazu; Nii, Keiji; Sase, Hitoshi; Ohta, Atsushi; Kojima, Tetsuo; Iikura, Hitoshi; Tanada, Mikimasa; Shiraishi, Takuya
Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough Targets

验证一种新方法，以创建超出5规则的口服药物，用于细胞内艰难的目标

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
IF15.6
2023-10-2432
PRE
Ohta, Atsushi; Tanada, Mikimasa; Shinohara, Shojiro; Morita, Yuya; Nakano, Kazuhiko; Yamagishi, Yusuke; Takano, Ryusuke; Kariyuki, Shiori; Iida, Takeo; Matsuo, Atsushi; Ozeki, Kazuhisa; Emura, Takashi; Sakurai, Yuuji; Takano, Koji; Higashida, Atsuko; Kojima, Miki; Muraoka, Terushige; Takeyama, Ryuuichi; Kato, Tatsuya; Kimura, Kaori; Ogawa, Kotaro; Ohara, Kazuhiro; Tanaka, Shota; Kikuchi, Yasufumi; Hisada, Nozomi; Hayashi, Ryuji; Nishimura, Yoshikazu; Nomura, Kenichi; Tachibana, Tatsuhiko; Irie, Machiko; Kawada, Hatsuo; Torizawa, Takuya; Murao, Naoaki; Kotake, Tomoya; Tanaka, Masahiko; Ishikawa, Shiho; Miyake, Taiji; Tamiya, Minoru; Arai, Masako; Chiyoda, Aya; Akai, Sho; Sase, Hitoshi; Kuramoto, Shino; Ito, Toshiya; Shiraishi, Takuya; Kojima, Tetsuo; Iikura, Hitoshi
Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS Inhibitor

开发靶向细胞内蛋白的口服生物可利用肽: 从命中到临床KRAS抑制剂

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
IF15.6
2023-07-1848
PRE
Tanada, Mikimasa; Tamiya, Minoru; Matsuo, Atsushi; Chiyoda, Aya; Takano, Koji; Ito, Toshiya; Irie, Machiko; Kotake, Tomoya; Takeyama, Ryuuichi; Kawada, Hatsuo; Hayashi, Ryuji; Ishikawa, Shiho; Nomura, Kenichi; Furuichi, Noriyuki; Morita, Yuya; Kage, Mirai; Hashimoto, Satoshi; Nii, Keiji; Sase, Hitoshi; Ohara, Kazuhiro; Ohta, Atsushi; Kuramoto, Shino; Nishimura, Yoshikazu; Iikura, Hitoshi; Shiraishi, Takuya
Peripheral CD4 memory T cells predict the efficacy of immune checkpoint inhibitor therapy in patients with non-small cell lung cancer

外周血CD4记忆性T细胞预测免疫检查点抑制剂治疗非小细胞肺癌的疗效

SCIENTIFIC REPORTS
IF3.9
2023-07-046
OAAI
Inomata, Minehiko; Matsumoto, Masahiro; Takata, Naoki; Hayashi, Kana; Seto, Zenta; Hirai, Takahiro; Tokui, Kotaro; Taka, Chihiro; Okazawa, Seisuke; Kambara, Kenta; Imanishi, Shingo; Miwa, Toshiro; Hayashi, Ryuji; Matsui, Shoko; Tobe, Kazuyuki

研究方向

暂未获取到该数据
S
Shoko Matsui
H 指数:35论文数:180被引数:1.0万
S
Shinya Kajiura
H 指数:14论文数:159被引数:769
K
Kazuyuki Tobe
H 指数:88论文数:441被引数:4.0万
M
Masashi Kobayashi
H 指数:66论文数:725被引数:1.6万
M
Muneharu Maruyama
H 指数:20论文数:96被引数:1,621
M
Minehiko Inomata
H 指数:15论文数:104被引数:685
E
Eiji Sugiyama
H 指数:34论文数:178被引数:4,313
S
Seisuke Okazawa
H 指数:15论文数:75被引数:631
T
Toshiro Miwa
H 指数:12论文数:78被引数:509
S
Shingo Imanishi
H 指数:11论文数:55被引数:515